Large-scale testing (Phase 3)Active Not RecruitingNCT04704921
What this trial is testing
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+6 more
AbbVie 671